These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16545911)

  • 1. Cancer-related bone pain is attenuated by a systemically available delta-opioid receptor agonist.
    Brainin-Mattos J; Smith ND; Malkmus S; Rew Y; Goodman M; Taulane J; Yaksh TL
    Pain; 2006 May; 122(1-2):174-81. PubMed ID: 16545911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and spinal analgesic activity of a delta-opioid-selective lanthionine enkephalin analog.
    Svensson CI; Rew Y; Malkmus S; Schiller PW; Taulane JP; Goodman M; Yaksh TL
    J Pharmacol Exp Ther; 2003 Feb; 304(2):827-32. PubMed ID: 12538839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evaluation of opioid and non-opioid analgesics in a murine bone cancer model of pain.
    Mouedden ME; Meert TF
    Pharmacol Biochem Behav; 2007 Mar; 86(3):458-67. PubMed ID: 17306872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a selective role of the delta-opioid agonist [8R-(4bS*,8aalpha,8abeta, 12bbeta)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neuropathic pain responses.
    Petrillo P; Angelici O; Bingham S; Ficalora G; Garnier M; Zaratin PF; Petrone G; Pozzi O; Sbacchi M; Stean TO; Upton N; Dondio GM; Scheideler MA
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1079-89. PubMed ID: 14551288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic effects of loperamide in bone cancer pain in mice.
    Menéndez L; Lastra A; Meana A; Hidalgo A; Baamonde A
    Pharmacol Biochem Behav; 2005 May; 81(1):114-21. PubMed ID: 15894068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of different subtypes of opioid receptors in mediating the ventrolateral orbital cortex opioid-induced inhibition of mirror-neuropathic pain in the rat.
    Zhao M; Wang JY; Jia H; Tang JS
    Neuroscience; 2007 Feb; 144(4):1486-94. PubMed ID: 17184926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
    Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
    Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
    Holdridge SV; Cahill CM
    Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
    Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
    Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence.
    Codd EE; Carson JR; Colburn RW; Stone DJ; Van Besien CR; Zhang SP; Wade PR; Gallantine EL; Meert TF; Molino L; Pullan S; Razler CM; Dax SL; Flores CM
    J Pharmacol Exp Ther; 2009 Apr; 329(1):241-51. PubMed ID: 19151246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral antinociceptive effects of mu- and delta-opioid receptor agonists in NOS2 and NOS1 knockout mice during chronic inflammatory pain.
    Leánez S; Hervera A; Pol O
    Eur J Pharmacol; 2009 Jan; 602(1):41-9. PubMed ID: 19041302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin attenuates the development of antinociceptive tolerance to delta-, but not to mu-opioid receptor agonist in mice.
    Dai X; Cui SG; Li SR; Chen Q; Wang R
    Behav Brain Res; 2007 Aug; 182(1):21-7. PubMed ID: 17568695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous injection of leconotide, an omega conotoxin: synergistic antihyperalgesic effects with morphine in a rat model of bone cancer pain.
    Kolosov A; Aurini L; Williams ED; Cooke I; Goodchild CS
    Pain Med; 2011 Jun; 12(6):923-41. PubMed ID: 21539704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain.
    Yamamoto J; Kawamata T; Niiyama Y; Omote K; Namiki A
    Neuroscience; 2008 Feb; 151(3):843-53. PubMed ID: 18178319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nefopam and ketoprofen synergy in rodent models of antinociception.
    Girard P; Verniers D; Coppé MC; Pansart Y; Gillardin JM
    Eur J Pharmacol; 2008 Apr; 584(2-3):263-71. PubMed ID: 18316069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
    Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
    Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of acute morphine-induced analgesia measured by a thermal test in bone cancer-bearing mice.
    González-Rodríguez S; Llames S; Hidalgo A; Baamonde A; Menéndez L
    Fundam Clin Pharmacol; 2012 Jun; 26(3):363-72. PubMed ID: 21306432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxycodone-induced analgesic effects in a bone cancer pain model in mice.
    Kato A; Minami K; Ito H; Tomii T; Matsumoto M; Orita S; Kihara T; Narita M; Suzuki T
    Oncology; 2008; 74 Suppl 1():55-60. PubMed ID: 18758199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.